| Model Number |
NA-U200H-8022 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Peritonitis (2252); Unspecified Hepatic or Biliary Problem (4493)
|
| Date of Event |
10/05/2022
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Olympus reviewed the following literature titled, "feasibility of endoscopic ultrasound-guided hepaticogastrostomy using a 22-gauge needle." this single-center retrospective study aimed to evaluate the feasibility of performing endoscopic ultrasound-guided hepaticogastrostomy using a 22-gauge fine-needle aspiration needle in 14 patients.Overall technical success was achieved in 11 cases (78.6%) and subsequently, 11 cases of technical success were analyzed.Clinical success was achieved in all the cases.The procedure time ranged from 15 to 93 minutes, with a median duration of 35 minutes.This study concludes that eus-hgs using a 22-gauge fna needle is initially effective.However, in 72.7% of the cases started using the 0.018-inch guidewire, the guidewire was exchanged for a 0.025-inch guidewire during procedure.Type of adverse events/number of patients: biliary peritonitis - 4 patients.Biloma - 1 patient.Since the literature described "22g ez shot 3plus", we selected "na-u200h-8022" as a representative product.This medwatch is being submitted for the na-u200h-8022 single-use aspiration needle, with patient identifier (b)(6).The scope referenced within the literature, gf-uct260 evis lucera ultrasound gastrovideoscope, is being submitted under the medwatch with patient identifier (b)(6).
|
| |
|
Additional Manufacturer Narrative
|
|
The subject device was not returned to olympus for evaluation.The device history record was not able to be reviewed for this device since the serial number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.As a result of reviewing the literature, it was confirmed that no malfunction related to the product was stated in the literature.Based on the legal manufacturer's investigation, since the literature did not describe any defects related to the product, it is considered that this event was not caused by a defect of the product.The root cause could not be determined.The literature article is attached for additional information.Olympus will continue to monitor field performance for this device.
|
| |
|
Additional Manufacturer Narrative
|
|
This supplemental report is being submitted to provide new information received from the author.This information has been added to b5.Also, corrections were made to d8, g2 and h6.Information added to these fields that were inadvertently not included on the initial medwatch.Olympus will continue to monitor field performance for this device.
|
| |
|
Event or Problem Description
|
|
The following information was received from the author: an olympus device did not cause or contribute to any of the adverse events described in the article.Also, an olympus device did not malfunction during any of the procedures.
|
| |
|
Search Alerts/Recalls
|